
The Excess Returns model looks at how much profit a company earns on its equity above the return that investors typically require, then capitalizes that surplus to estimate what the shares could be worth.
For Mercury General, the starting point is a Book Value of $43.64 per share and a Stable Book Value of $29.78 per share, based on the median figure from the past 5 years. Using an Average Return on Equity of 17.35%, the model arrives at a Stable EPS of $5.17 per share, sourced from that historical median return pattern.
The Cost of Equity is estimated at $2.08 per share, which leaves an Excess Return of $3.09 per share. In simple terms, the company is modeled as earning more on its equity base than the required return. Those excess profits are what drive the intrinsic value higher.
Putting this together, the Excess Returns framework points to an intrinsic value of about $116.38 per share compared with a recent price of around $87.85, suggesting the stock is 24.5% undervalued on this measure.
Result: UNDERVALUED
Our Excess Returns analysis suggests Mercury General is undervalued by 24.5%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.
For a profitable insurer like Mercury General, the P/E ratio is a useful shorthand for what investors are currently willing to pay for each dollar of earnings. It ties the share price directly to the company’s profit, which is usually a key driver of long term returns.
What counts as a “normal” or “fair” P/E depends on what investors expect from a company’s future earnings and how risky those earnings appear to be. Higher expected growth or lower perceived risk often goes with a higher P/E, while lower growth expectations or higher risk tend to justify a lower multiple.
Mercury General currently trades on a P/E of 8.99x. That compares with an Insurance industry average P/E of 11.42x and a peer group average of 9.30x. Simply Wall St’s Fair Ratio for Mercury General is 8.97x, which reflects a proprietary assessment of the company’s earnings profile that factors in its industry, profit margins, size and risk characteristics. This Fair Ratio can be more informative than a simple comparison with industry or peers because it is tailored to Mercury General’s specific fundamentals rather than broad group averages. With the actual P/E of 8.99x sitting very close to the Fair Ratio of 8.97x, the shares appear to be fairly priced on this metric.
Result: ABOUT RIGHT
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.
Earlier this article mentioned that there is an even better way to understand valuation. Narratives let you connect your view of Mercury General’s story to numbers by turning your assumptions about future revenue, earnings, margins and fair value into a clear forecast that can be compared with today’s price on the Simply Wall St Community page. These Narratives update automatically when fresh information such as news or earnings is added. Different investors can set very different fair values. For example, one Narrative might focus on technological disruption in personal auto and arrive at a fair value near the lower end of about US$68.90. Another focuses on core underwriting strength, capital generation and analyst assumptions to reach a fair value closer to the higher end of about US$142.50. This can help you decide how the current price lines up with the story you believe.
Do you think there's more to the story for Mercury General? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com